Listed

Macrogenics Inc

MGNXNasdaqCIK 1125345HealthcareFiscal year ends Dec 31

Reports and events: 228 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Macrogenics Inc, Reports and events
FiledFormWhat it isAccession number
2024-04-0317:24 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001125345-24-000065
2024-03-0716:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001125345-24-000061
2024-03-0716:03 ET10-KAnnual reportPeriod 2023-12-310001125345-24-000060
2023-11-0616:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001125345-23-000125
2023-11-0616:03 ET10-QQuarterly reportPeriod 2023-09-300001125345-23-000124
2023-09-2216:42 ET8-K1.02 Termination of a material agreement0001125345-23-000113
2023-08-0916:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001125345-23-000109
2023-08-0916:03 ET10-QQuarterly reportPeriod 2023-06-300001125345-23-000108
2023-06-0208:39 ET8-K5.07 Shareholder vote results0001125345-23-000081
2023-05-0916:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001125345-23-000077
2023-05-0916:04 ET10-QQuarterly reportPeriod 2023-03-310001125345-23-000076
2023-04-1716:01 ETDEF 14AProxy statementPeriod 2023-05-310001125345-23-000067
2023-03-2416:33 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001125345-23-000063
2023-03-1516:07 ET10-KAnnual reportPeriod 2022-12-310001125345-23-000059
2023-03-1516:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001125345-23-000058
2023-03-1016:38 ET8-K7.01 Regulation FD disclosure0001125345-23-000047
2023-03-0908:01 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001125345-23-000045
2023-02-1418:12 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001125345-23-000021
2023-01-0508:28 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001125345-23-000011
2022-12-2116:09 ET8-K5.02 Departure or appointment of officers or directors0001125345-22-000113
2022-12-1616:28 ET8-K1.01 Entry into a material agreement0001125345-22-000111
2022-11-1818:42 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001125345-22-000108
2022-11-0316:03 ET10-QQuarterly reportPeriod 2022-09-300001125345-22-000104
2022-11-0316:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001125345-22-000103
2022-10-1716:22 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001125345-22-000092
2022-08-0816:04 ET10-QQuarterly reportPeriod 2022-06-300001125345-22-000090
2022-08-0816:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001125345-22-000089
2022-07-0817:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001125345-22-000080
2022-05-2408:38 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001125345-22-000070
2022-05-2317:01 ET8-K5.07 Shareholder vote results0001125345-22-000053
2022-05-0316:04 ET10-QQuarterly reportPeriod 2022-03-310001125345-22-000047
2022-05-0316:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001125345-22-000046
2022-04-0816:06 ETDEF 14AProxy statementPeriod 2022-05-190001125345-22-000039
2022-02-2416:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001125345-22-000014
2022-02-2416:06 ET10-KAnnual reportPeriod 2021-12-310001125345-22-000013
2022-01-0718:46 ET8-K5.02 Departure or appointment of officers or directors0001125345-22-000003
2021-11-0216:05 ET10-QQuarterly reportPeriod 2021-09-300001125345-21-000115
2021-11-0216:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001125345-21-000114
2021-09-2716:12 ET8-K5.02 Departure or appointment of officers or directors0001125345-21-000107
2021-09-1616:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001125345-21-000105
2021-09-0816:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001125345-21-000103
2021-07-2916:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001125345-21-000100
2021-07-2916:03 ET10-QQuarterly reportPeriod 2021-06-300001125345-21-000099
2021-06-1616:55 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001125345-21-000087
2021-05-1817:01 ET8-K5.07 Shareholder vote results0001125345-21-000082
2021-04-2917:12 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-21-015000
2021-04-2916:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001125345-21-000061
2021-04-2916:02 ET10-QQuarterly reportPeriod 2021-03-310001125345-21-000060
2021-04-0219:44 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001125345-21-000052
2021-04-0218:46 ETDEF 14AProxy statementPeriod 2021-05-130001125345-21-000049

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 00:17 ET. Listed shows no prices and gives no investment advice.